BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 2752476)

  • 1. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.
    Helissey P; Giorgi-Renault S; Renault J; Cros S
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones.
    Helissey P; Giorgi-Renault S; Renault J; Cros S
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convenient synthesis of 1H-pyrrolo[3,2-c]quinoline-6,9-diones and 11H-indolo[3,2-c]quinoline-1,4-diones derivatives.
    Helissey P; Parrot-Lopez H; Renault J; Cros S
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3547-57. PubMed ID: 3435963
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
    Helissey P; Cros S; Giorgi-Renault S
    Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-mutagenicity relationships in series of 11H-indolo[3,2-c]quinoline-1,4-diones, tetrahydro-11H-indolo[3,2-c]quinoline-1,4-diones and 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones with leukemia cytotoxic properties. Relations with topoisomerase I inhibiting properties.
    Callais F; Helissey P; Min S; Festy B; Giorgi-Renault S
    Mutat Res; 1994 Nov; 311(1):149-56. PubMed ID: 7526168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
    Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
    Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern--synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives.
    He L; Chang HX; Chou TC; Savaraj N; Cheng CC
    Eur J Med Chem; 2003 Jan; 38(1):101-7. PubMed ID: 12593920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro cytotoxic effect of 6-amino-substituted 11H- and 11Me-indolo[3,2-c]quinolines.
    Wang N; Świtalska M; Wu MY; Imai K; Ngoc TA; Pang CQ; Wang L; Wietrzyk J; Inokuchi T
    Eur J Med Chem; 2014 May; 78():314-23. PubMed ID: 24686018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-assisted Synthesis of 6-substituted indolo[2,3-b]quinolines: their Evaluation as Potential Cytotoxic Agents.
    Marepu N; Gosi M; Vedula SS; Yeturu S; Pal M
    Mini Rev Med Chem; 2019; 19(7):599-608. PubMed ID: 30058486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines.
    Takeuchi Y; Chang MR; Hashigaki K; Tashiro T; Tsuruo T; Tsukagoshi S; Yamato M
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1481-5. PubMed ID: 1394666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
    Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
    J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of fused quinoline derivatives. V. Methylindolo[3,2-b]quinolines.
    Takeuchi Y; Kitaomo M; Chang MR; Shirasaka S; Shimamura C; Okuno Y; Yamato M; Harayama T
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2096-9. PubMed ID: 9433781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C
    Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiproliferative evaluation of certain indolo[3,2-c]quinoline derivatives.
    Lu CM; Chen YL; Chen HL; Chen CA; Lu PJ; Yang CN; Tzeng CC
    Bioorg Med Chem; 2010 Mar; 18(5):1948-57. PubMed ID: 20171108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indolo[3,2-c]quinoline G-quadruplex stabilizers: a structural analysis of binding to the human telomeric G-quadruplex.
    Lavrado J; Ohnmacht SA; Correia I; Leitão C; Pisco S; Gunaratnam M; Moreira R; Neidle S; Santos DJ; Paulo A
    ChemMedChem; 2015 May; 10(5):836-49. PubMed ID: 25820698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of 7-(N-glycosylamino)-indolo[3,2-b]quinolines.
    Takeuchi Y; Chang MR; Hashigaki K; Yamato M
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1629-31. PubMed ID: 1934189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxic activity evaluation of indolo-, pyrrolo-, and benzofuro-quinolin-2(1H)-ones and 6-anilinoindoloquinoline derivatives.
    Chen YL; Chung CH; Chen IL; Chen PH; Jeng HY
    Bioorg Med Chem; 2002 Aug; 10(8):2705-12. PubMed ID: 12057659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative one-pot gold-catalyzed approach to the assembly of 11H-indolo[3,2-c]quinolines.
    Abbiati G; Arcadi A; Chiarini M; Marinelli F; Pietropaolo E; Rossi E
    Org Biomol Chem; 2012 Oct; 10(38):7801-8. PubMed ID: 22911041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of methoxy-indolo[2,1-a]isoquinolines.
    Ambros R; von Angerer S; Wiegrebe W
    Arch Pharm (Weinheim); 1988 Aug; 321(8):481-6. PubMed ID: 3223806
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and antifungal activity of 1H-pyrrolo[3,2-g]quinoline-4,9-diones and 4,9-dioxo-4,9-dihydro-1H-benzo[f]indoles.
    Ryu CK; Lee JY; Jeong SH; Nho JH
    Bioorg Med Chem Lett; 2009 Jan; 19(1):146-8. PubMed ID: 19010669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.